8th Drug Formulation, Solubility & Bioavailability – 8th Drug Formulation, Solubility & Bioavailability Summit
While still facing evergreen problems with API solubility, formulation professionals are finding new areas for growth in immuno-oncology, regenerative therapies, and controlled release delivery. And beyond purely technical questions, in an increasingly connected workplace the need for improved teamwork is stronger than ever. ExL’s 8th Drug Formulation, Solubility & Bioavailability conference is a unique strategic forum where R&D professionals gather to review and rank the latest technological options for drug formulation and delivery, while also bridging the gaps of understanding that may exist between team members.
Because YOU demanded it – a full-day interactive seminar about the development and modeling of amorphous solid dispersions! Featuring in-depth discussions of shelf-life and toxicology challenges, outsourcing decisions, development for nanoparticles and generics – and much more!
Top Five Reasons to Attend
Focus on stronger teamwork between formulation and medicinal chemistry
New insights on continuous manufacturing during early development
Improved drug delivery options for immuno-oncology and regenerative medicines
Innovative CNS delivery methods across the blood-brain barrier
Strategies to select the least painful drug delivery methods
Who Should Attend
Pharmaceutical, biotech and medical device professionals responsible for the following areas: